Posted in | News | Mining Business

Carpathian Gold Closes Extended Forbearance and Amendment Agreement with Macquarie Bank

Carpathian Gold Inc. (the "Corporation" or "Carpathian") advises that it has concluded a further extended forbearance and amendment agreement (the "Agreement") with Macquarie Bank Limited ("Macquarie").

The Agreement provides for a US$5 million increase in the amount of funds made available under Tranche 3 of the project finance facility entered into between Macquarie and the Corporation's wholly-owned subsidiary, Mineração Riacho dos Machados Ltda. ("MRDM"), for a total facility of up to US$170 million of which approximately $US164.9 million is currently drawn. Under the terms of the Agreement, the forbearance expires on July 31, 2014, with repayment of any funds drawn down under Tranche 3 to be effected by December 31, 2014. There is no assurance that any or all of the funds to be provided to MRDM under the terms of the Agreement will actually be made available to it as any disbursements thereof remain solely at Macquarie's discretion, nor is there any assurance that Macquarie will agree to any further extensions of the forbearance.

Carpathian also wishes to announce that Mr. Rishi Tibriwal, Chief Financial Officer of the Corporation, has left to pursue other opportunities and that Mr. Carlos Pinglo has been appointed as his replacement. Mr. Pinglo is an economist with over 20 years senior management experience, including working as Chief Financial Officer for a number of public companies as well as in corporate finance, strategic planning, financial reporting, turnarounds and mergers & acquisitions.

About Carpathian

Carpathian is an exploration and development company whose primary business interest is developing near-term gold production at its 100% owned Riacho dos Machados Gold Project in Brazil. In addition, it is also focussed on advancing its exploration and development plans on its 100% owned Rovina Valley Au-Cu Project located in Romania.

Source: http://www.carpathiangold.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.